Genetic basis of carbapenem resistance in Acinetobacter clinical isolates in Saudi Arabia

African Journal of Biotechnology

Volumn 10, Issue 64, 2011, Pages 14186-14196

  Al Arfaj, Abdullah A ^a   Ibrahim, Abdelnasser S S ^a   Somily, Ali Mohammed ^a   Al Salamah, Ali A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Acinetobacter baumannii; Multi drug resistance; Oxacillinases; lactam

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFACLOR; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CEFUROXIME AXETIL; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; GENE; GENE SEQUENCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OXACILLINASE GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PUBLIC HOSPITAL; SAUDI ARABIA; UNIVERSITY HOSPITAL;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

EID: 80054849848     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: 10.5897/ajb11.2291     Document Type: Article

References (31)

1. Al-Tawfiq A, Mohandhas A, Hangiah T (2007). Prevalence of antimicrobial resistance in Acinetobacter calcoaceticus-baumannii complex in a Saudi Arabian hospital. Infect. Control. Hospit. Epidemiol. 28: 870-872.
2. Bertini A, Poirel L, Bernabeu S, Fortini D, Villa L, Nordmann P, Carattoli A (2007). Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob. Agents Chemother. 51(7): 2324-2328.
3. Bogaerts P, Naas T, El-Garch F, Cuzon G, Deplano A, Delaire T, Huang T, Lissoir B, Nordmann P, Glupczynski Y (2010).GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob. Agents Chemother. 54(11): 4872-4878.
4. Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L (2011). Carbapenem-hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 55(1): 349-354.
5. Bukhary Z, Mahmood W, Al-Khani A, Al-Abdely HM (2005). Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin. Saudi. Med. J. 26 (4): 656-658.
6. Chen T, Lee Y, Kuo S, Hsueh P, Chang F, Siu L, Ko W, Fung C (2010). Emergence and distribution of plasmids bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. J. Antimicrob. Chemother. 54(11): 4575-4581.
7. Constantiniu S, Romaniuc A, Iancu L, Filimon R, Tarasi I (2004). Cultural and biochemical characteristics of Acinetobacter spp. Strains isolated from hospital units. J. Prevent. Med. 12(34): 35-42.
8. Dalla-Costa LM., Coelho JM, Souza HA, Castro ME, Stier CN, Bragagnolo KL, Neto AR, Penteado-Filho SR, Livermore DM, Woodford N (2003). Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba. Brazil. J. Clin. Microbiol. 41(7): 3403-3406.
9. Eltahawy AT, Khalaf RM (2001). Antibiotic resistance among Gramnegative non fermentative bacteria at a teaching hospital in Saudi Arabia. J. Chemother. 13(3): 260-264.
10. Hanan AB, Kambal AM, Al-Anazy AR, Saidu AB, Aziz S (2003). Acinetobacter Blood Stream Infection in a Teaching Hospital-Riyadh, Saudi Arabia. Kuwait Med. J. 35(3): 196-201.
11. Heritier C, Poirel L, Fournier P, Claverie J, Raoult D, Nordmann P (2005). Characterization of the naturally occurring oxacillinase ofAcinetobacter baumannii. Antimicrob. Agents Chemother. 49(10): 4174-4179.
12. Ho PL, Ho AY, Chow KH, Lai EL, Ching P, Seto WH (2010). Epidemiology and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong. J. Hospital. Infect.74: 358-364.
13. Jeon BC, Jeong SH, Bae IK, Kwon S B, Lee K, Young D, Lee JH, Song J S, Lee SH (2005). Investigation of a nosocomial outbreak of imipenem resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J. Clin. Microbiol. 43: 2241-2245.
14. Kim C, Lee Y, Lee H, Woo G, Song W, Kim M, Lee W, Jeong S, Lee K, Chong Y (2010). Prevalence and diversity of carbapenemases among imipenem non-susceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn. Microbiol. Infect. Dis. 68(4): 432-438.
15. Koh T, Sng L, Wang G, Hsu L, Zhao Y (2007). IMP-4 and OXA b lactamases in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother. 59: 627-632.
16. Kulah C, Mooij MJ, Comerta F, Aktas E, Celebi G, Ozlu N, Rijnsburger MC, Savelkou PM (2010). Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey. Inter. J. Antimicrob. Agents. 36: 114-118.
17. Lee K, Park KH, Jeong SH, Lim HS, Shin JH, Yong D, Ha GY, Chong Y (2006). Further increase of vancomycin-resistant Enterococcus faecium, amikacin-and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Yonsei Med. J. 47: 43-54.
18. Liu SY, Lin JY, Chu C, Su LH, Lin TY Chiu CH (2006). Integron associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in Taiwan. Int. J. Antimicrob. Agents, 27: 81-84.
19. Mak JK, Kim MJ, Pham J, Tapsall J, White PA (2009). Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 63: 47-54.
20. Marque S, Poirel L, Heritier C, Brisse S, Blasco M, Filip R, Coman G, Naas T, Nordmann P (2005). Regional occurrence of plasmidmediated carbapenem hydrolyzing oxacillinase OXA 58 in Acinetobacter spp. in Europe. J. Clin. Microbiol. 43: 4885-4888.
21. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P (2005). Outbreak of carbapenem resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J. Clin. Microbiol. 43: 4826 4829.
22. Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Nakamura T, Wada Y, Orita T, Kofuku T, Yamasaki K, Sakamoto M, Kinoshita S, Aihara M, Arakawa Y (2004). Metallo-β-lactamase producing gram negative bacilli: laboratorybased surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J. Clin. Microbiol. 42: 5256-5263.
23. Park YS, Lee H, Lee KS, Hwang SS, Cho YK, Kim HY, Uh Y, Chin BS, Han SH, Jeong SH, Lee K., Kim JM (2010). Extensively drug resistant Acinetobacter baumannii: risk factors for acquisition and prevalent OXA-type carbapenemases-a multicentre study. Int. J. Antimicrob Agents, 36(5): 430-35.
24. Peleg A, Seifert H, Paterson DL (2008). Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 21: 538-582.
25. Perez F, Hujer AM, Hujer KM, Decker BK (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 51(10): 3471-3484.
26. Poirel L, Corvec S, Rapoport M, Mugnier P, Petroni A, Pasteran F, Faccone D, Galas M, Drugeon H, Cattoir V, Nordmann P (2007). Identification of the novel narrow-spectrum β-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob. Agents Chemother. 51: 2179-2184.
27. Poirel L, Naas T, Nordmann P (2010). Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54(1): 24-38.
28. Qi C, Malczynski M, Parker M, Scheetz MH (2008). Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains Collected from 2004 to 2007. J. Clinic. Microbiol. 46:1106-1109.
29. Tian GB, Adams-Haduch JM, Bogdanovich T, Pasculle AW, Quinn JP, Wang HN, Doi Y (2011). Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania. Antimicrob. Agents Chemother. 55(1): 429-432.
30. Villalon P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, Saez-Nieto JA (2011). Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J. Clin. Microbiol. 49(3): 875-882.
31. Zarrilli R, Vitale D, Popolo A, Bagattini M, Daoud Z, Khan A, Afif C, Triassi M (2008). A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob. Agents Chemother. 52(11): 4115-4120.